Transform Cardiovascular Risk in Diabetes (TRANSFORM CVRiD)


What You Will Learn

  • Key considerations and practical application tips from the latest trials.
  • Mechanisms of action, indications, dosing, contradictions, cautions, and adverse events for the SGLT2i drugs and GLP-1 RA drugs.
  • Practical tips for drug initiation.
  • How to implement guideline-directed medical therapy with a care team.



Patient Case Quizzes

Listen to experts discuss the latest clinical education


We are grateful to these distinguished faculty who contributed to this collection:

Pam R. Taub, MD, FACC (Chair)


Laurence S. Sperling, MD, FACC


Robert H. Eckel, MD


Leigh Perreault, MD


Vanita Aroda, MD


Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES


Melissa Magwire, CDE, MSN, RN


Neil S. Skolnik, MD 


Jandra Hancock, APRN, FNP-C, CDCES


Kristin Repp, PharmD


Eden Miller, DO


Educational Grant Support Provided By: Novo Nordisk | Page Launched: February 2022

Android App Download IOS App Download Powered By